Published in Bioinformatics on February 17, 2009
Self-contained gene-set analysis of expression data: an evaluation of existing and novel methods. PLoS One (2010) 1.67
Independent component analysis: mining microarray data for fundamental human gene expression modules. J Biomed Inform (2010) 1.39
Principal component analysis based methods in bioinformatics studies. Brief Bioinform (2011) 1.31
Detection of gene pathways with predictive power for breast cancer prognosis. BMC Bioinformatics (2010) 1.12
A network-based gene-weighting approach for pathway analysis. Cell Res (2011) 0.94
Incorporating higher-order representative features improves prediction in network-based cancer prognosis analysis. BMC Med Genomics (2011) 0.90
Characteristic gene selection via weighting principal components by singular values. PLoS One (2012) 0.87
EDDY: a novel statistical gene set test method to detect differential genetic dependencies. Nucleic Acids Res (2014) 0.87
Systems analysis of high-throughput data. Adv Exp Med Biol (2014) 0.87
Identification of aberrant pathways and network activities from high-throughput data. Brief Bioinform (2012) 0.85
Genetic and nongenetic variation revealed for the principal components of human gene expression. Genetics (2013) 0.83
Characterization of changes in gene expression and biochemical pathways at low levels of benzene exposure. PLoS One (2014) 0.83
A class-information-based penalized matrix decomposition for identifying plants core genes responding to abiotic stresses. PLoS One (2014) 0.82
Principal component gene set enrichment (PCGSE). BioData Min (2015) 0.81
Multivariate inference of pathway activity in host immunity and response to therapeutics. Nucleic Acids Res (2014) 0.79
A P-Norm Robust Feature Extraction Method for Identifying Differentially Expressed Genes. PLoS One (2015) 0.78
Adaptive elastic-net sparse principal component analysis for pathway association testing. Stat Appl Genet Mol Biol (2011) 0.78
GO2MSIG, an automated GO based multi-species gene set generator for gene set enrichment analysis. BMC Bioinformatics (2014) 0.78
A novel hybrid dimension reduction technique for undersized high dimensional gene expression data sets using information complexity criterion for cancer classification. Comput Math Methods Med (2015) 0.76
Multiple Natural and Experimental Inflammatory Rabbit Lacrimal Gland Phenotypes. Ocul Surf (2016) 0.75
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46
Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science (1999) 83.27
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med (2002) 24.07
Microarray data analysis: from disarray to consolidation and consensus. Nat Rev Genet (2006) 16.12
A global test for groups of genes: testing association with a clinical outcome. Bioinformatics (2004) 10.82
Analyzing gene expression data in terms of gene sets: methodological issues. Bioinformatics (2007) 9.87
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell (2003) 6.11
Gene-set approach for expression pattern analysis. Brief Bioinform (2008) 4.58
Principal component analysis for clustering gene expression data. Bioinformatics (2001) 4.35
Extensions to gene set enrichment. Bioinformatics (2006) 4.26
A general modular framework for gene set enrichment analysis. BMC Bioinformatics (2009) 3.92
Pathways to the analysis of microarray data. Trends Biotechnol (2005) 3.88
A web-based tool for principal component and significance analysis of microarray data. Bioinformatics (2005) 3.42
Genome-wide association study and mouse model identify interaction between RET and EDNRB pathways in Hirschsprung disease. Nat Genet (2002) 2.74
A multivariate approach for integrating genome-wide expression data and biological knowledge. Bioinformatics (2006) 2.42
Nonparametric pathway-based regression models for analysis of genomic data. Biostatistics (2006) 2.28
Gene selection using support vector machines with non-convex penalty. Bioinformatics (2005) 2.16
Supervised principal component analysis for gene set enrichment of microarray data with continuous or survival outcomes. Bioinformatics (2008) 1.45
High-throughput retroviral tagging for identification of genes involved in initiation and progression of mouse splenic marginal zone lymphomas. Cancer Res (2004) 1.38
Identification of differentially expressed gene categories in microarray studies using nonparametric multivariate analysis. Bioinformatics (2007) 1.33
Gene set analyses for interpreting microarray experiments on prokaryotic organisms. BMC Bioinformatics (2008) 1.11
Non-linear tests for identifying differentially expressed genes or genetic networks. Bioinformatics (2006) 1.04
Building pathway clusters from Random Forests classification using class votes. BMC Bioinformatics (2008) 0.89
Molecular control of the cell cycle in cancer: biological and clinical aspects. Dan Med Bull (2003) 0.87
Natural cell-mediated cytotoxicity in cutaneous T-cell lymphomas. J Invest Dermatol (1983) 0.80
[Tyrosine metabolism in leukemia]. Probl Gematol Pereliv Krovi (1971) 0.80
Identifying subset of genes that have influential impacts on cancer progression: a new approach to analyze cancer microarray data. Funct Integr Genomics (2008) 0.78
In vitro modulation of natural killer cell activity in non-Hodgkin's lymphoma patients after therapy. Cancer Immunol Immunother (1989) 0.78
Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA (2005) 3.49
Reinforcement learning design for cancer clinical trials. Stat Med (2009) 3.15
Estimating Individualized Treatment Rules Using Outcome Weighted Learning. J Am Stat Assoc (2012) 3.13
Relationships among specific viral pathogens, virus-induced interleukin-8, and respiratory symptoms in infancy. Pediatr Allergy Immunol (2002) 2.72
Simultaneous inferences on the contrast of two hazard functions with censored observations. Biometrics (2002) 2.18
Reinforcement learning strategies for clinical trials in nonsmall cell lung cancer. Biometrics (2011) 2.17
Q-LEARNING WITH CENSORED DATA. Ann Stat (2012) 1.85
Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors. JAMA (2002) 1.76
Reproducibility of a scoring system for computed tomography scanning in cystic fibrosis. J Thorac Imaging (2006) 1.56
Additive risk models for survival data with high-dimensional covariates. Biometrics (2006) 1.48
A controlled, randomized, double-blind trial of prophylaxis against jaundice among breastfed newborns. Pediatrics (2005) 1.47
Association between mucoid Pseudomonas infection and bronchiectasis in children with cystic fibrosis. Radiology (2009) 1.42
Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough! J Pediatr (2005) 1.36
Longitudinal evaluation of bronchopulmonary disease in children with cystic fibrosis. Pediatr Pulmonol (2003) 1.35
Bronchopulmonary disease in children with cystic fibrosis after early or delayed diagnosis. Am J Respir Crit Care Med (2003) 1.29
Temper tantrums in young children: 2. Tantrum duration and temporal organization. J Dev Behav Pediatr (2003) 1.24
Association between initial disease presentation, lung disease outcomes, and survival in patients with cystic fibrosis. Am J Epidemiol (2004) 1.22
Nonparametric association analysis of exchangeable clustered competing risks data. Biometrics (2008) 1.13
Detection of gene pathways with predictive power for breast cancer prognosis. BMC Bioinformatics (2010) 1.12
Recursively Imputed Survival Trees. J Am Stat Assoc (2011) 1.07
On semiparametric efficient inference for two-stage outcome-dependent sampling with a continuous outcome. Biometrika (2009) 1.05
A framework for understanding cancer comparative effectiveness research data needs. J Clin Epidemiol (2012) 1.00
Delayed diagnosis of US females with cystic fibrosis. Am J Epidemiol (2002) 0.99
Cognitive function of children with cystic fibrosis: deleterious effect of early malnutrition. Pediatrics (2004) 0.99
Simultaneous Critical Values For T-Tests In Very High Dimensions. Bernoulli (Andover) (2011) 0.96
Cystic fibrosis mutations and genotype-pulmonary phenotype analysis. J Cyst Fibros (2005) 0.95
Robust covariate-adjusted log-rank statistics and corresponding sample size formula for recurrent events data. Biometrics (2007) 0.94
Identification of predictive pathways for non-hodgkin lymphoma prognosis. Cancer Inform (2010) 0.93
The Penalized Profile Sampler. J Multivar Anal (2009) 0.92
Longitudinal pulmonary status of cystic fibrosis children with meconium ileus. Pediatr Pulmonol (2004) 0.91
Incorporating higher-order representative features improves prediction in network-based cancer prognosis analysis. BMC Med Genomics (2011) 0.90
Data for cancer comparative effectiveness research: past, present, and future potential. Cancer (2012) 0.89
On Asymptotically Optimal Tests Under Loss of Identifiability in Semiparametric Models. Ann Stat (2009) 0.88
Regional differences in the evolution of lung disease in children with cystic fibrosis. Pediatr Pulmonol (2011) 0.84
Preventing early, prolonged vitamin E deficiency: an opportunity for better cognitive outcomes via early diagnosis through neonatal screening. J Pediatr (2005) 0.83
Robust semiparametric microarray normalization and significance analysis. Biometrics (2006) 0.83
A sample size formula for the supremum log-rank statistic. Biometrics (2005) 0.80
Biclustering with heterogeneous variance. Proc Natl Acad Sci U S A (2013) 0.79
What we want versus what we can get: a closer look at failure time endpoints for cardiovascular studies. J Biopharm Stat (2008) 0.78
Medical records-based postmarketing safety evaluation of rare events with uncertain status. J Biopharm Stat (2013) 0.75
Medical records-based postmarketing safety evaluation of rare events with uncertain status. J Biopharm Stat (2013) 0.75
Detecting disease outbreaks using local spatiotemporal methods. Biometrics (2011) 0.75
The effects of state psychiatric hospital waitlist policies on length of stay and time to readmission. Adm Policy Ment Health (2015) 0.75
University of Pennsylvania 6th annual conference on statistical issues in clinical trials: Dynamic treatment regimes (morning session). Clin Trials (2014) 0.75
Latent Supervised Learning. J Am Stat Assoc (2013) 0.75
Comment on "Adaptive Confidence Intervals for the Test Error in Classification" J Am Stat Assoc (2011) 0.75
Inverse regression estimation for censored data. J Am Stat Assoc (2011) 0.75